$SLAB
Silicon Laboratories Inc Stock $slab

$slab Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000162828024032746 Filed on July 24, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$166.4M	$145.4M
YoY Change	-32.05%	-41.1%
Cost Of Revenue	$76.08M	$68.78M
YoY Change	-24.74%	-25.98%
Gross Profit	$90.31M	$76.58M
YoY Change	-37.18%	-50.23%
Gross Profit Margin	54.28%	52.68%
Selling, General & Admin	$36.79M	$38.70M
YoY Change	-9.61%	-13.8%
% of Gross Profit	40.74%	50.53%
Research & Development	$83.23M	$85.91M
YoY Change	-3.11%	-3.9%
% of Gross Profit	92.16%	112.18%
Depreciation & Amortization	$11.59M	$12.60M
YoY Change	-8.05%	102.07%
% of Gross Profit	12.83%	16.45%
Operating Expenses	$120.0M	$124.6M
YoY Change	-5.2%	-7.21%
Operating Profit	-$29.71M	-$48.02M
YoY Change	-273.05%	-345.34%
Interest Expense	$3.209M	$2.527M
YoY Change	-48.11%	52.6%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$26.50M	-$45.49M
YoY Change	-213.48%	-299.95%
Income Tax	$2.000M	$36.70M
% Of Pretax Income
Net Earnings	-$28.50M	-$82.16M
YoY Change	-360.17%	-688.22%
Net Earnings / Revenue	-17.13%	-56.52%
Basic Earnings Per Share	-$0.88	-$2.56
Diluted Earnings Per Share	-$0.88	-$2.56
COMMON SHARES
Basic Shares Outstanding	32.29M shares	31.92M shares
Diluted Shares Outstanding	32.31M shares	32.12M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$369.7M	$339.2M
YoY Change	-26.92%	-70.56%
Cash & Equivalents	$303.1M	$240.8M
Short-Term Investments	$66.60M	$98.34M
Other Short-Term Assets	$56.09M	$53.59M
YoY Change	-21.36%	-38.92%
Inventory	$139.5M	$166.1M
Prepaid Expenses
Receivables	$48.88M	$41.21M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$614.1M	$600.0M
YoY Change	-25.19%	-58.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$135.3M	$139.4M
YoY Change	-11.18%	-8.36%
Goodwill	$376.4M	$376.4M
YoY Change	0.0%	0.0%
Intangibles	$41.94M	$47.37M
YoY Change	-41.76%	-39.57%
Long-Term Investments
YoY Change
Other Assets	$81.46M	$86.78M
YoY Change	-16.08%	-7.49%
Total Long-Term Assets	$635.1M	$649.9M
YoY Change	-8.99%	-7.25%
TOTAL ASSETS
Total Short-Term Assets	$614.1M	$600.0M
Total Long-Term Assets	$635.1M	$649.9M
Total Assets	$1.249B	$1.250B
YoY Change	-17.75%	-42.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$44.65M	$39.30M
YoY Change	-18.97%	-44.99%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$118.3M	$100.1M
YoY Change	-45.87%	-85.56%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$49.55M	$56.85M
YoY Change	19.82%	16.81%
Total Long-Term Liabilities	$49.55M	$56.85M
YoY Change	19.82%	16.81%
TOTAL LIABILITIES
Total Short-Term Liabilities	$118.3M	$100.1M
Total Long-Term Liabilities	$49.55M	$56.85M
Total Liabilities	$167.9M	$157.0M
YoY Change	-35.42%	-78.85%
SHAREHOLDERS EQUITY
Retained Earnings	$1.026B	$1.054B
YoY Change	-18.8%	-26.08%
Common Stock	$3.000K	$3.000K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.081B	$1.093B
YoY Change
Total Liabilities & Shareholders Equity	$1.249B	$1.250B
YoY Change	-17.75%	-42.17%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$28.50M	-$82.16M
YoY Change	-360.17%	-688.22%
Depreciation, Depletion And Amortization	$11.59M	$12.60M
YoY Change	-8.05%	102.07%
Cash From Operating Activities	$31.63M	$16.13M
YoY Change	-1524.64%	-221.49%
INVESTING ACTIVITIES
Capital Expenditures	$2.208M	$3.530M
YoY Change	-61.96%	-53.9%
Acquisitions
YoY Change
Other Investing Activities	$32.41M	$43.14M
YoY Change	-80.67%	-83.53%
Cash From Investing Activities	$30.20M	$39.61M
YoY Change	-81.34%	-84.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	423.0K	-6.398M
YoY Change	-100.07%	-73.93%
NET CHANGE
Cash From Operating Activities	31.63M	16.13M
Cash From Investing Activities	30.20M	39.61M
Cash From Financing Activities	423.0K	-6.398M
Net Change In Cash	62.25M	49.35M
YoY Change	-112.93%	-77.2%
FREE CASH FLOW
Cash From Operating Activities	$31.63M	$16.13M
Capital Expenditures	$2.208M	$3.530M
Free Cash Flow	$29.42M	$12.60M
YoY Change	-466.59%	-160.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32289000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32289000	shares
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-3564000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1258897000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1208682000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-138683000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	771000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-7105000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	29364000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	1093029000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1405008000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	24923000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6598000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-8524000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	196962000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31418000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-3564000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	1258897000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-138683000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	24923000	usd
	us-gaap	Depreciation Depreciation	13152000	usd
	us-gaap	Depreciation Depreciation	12441000	usd
	slab	Amortization Of Intangibles And Other Assets AmortizationOfIntangiblesAndOtherAssets	12160000	usd
	slab	Amortization Of Intangibles And Other Assets AmortizationOfIntangiblesAndOtherAssets	12904000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	960000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	29455000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	31377000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1090000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	29784000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-6403000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11918000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	26819000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-28123000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	45064000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-20723000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-32963000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-19341000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30003000	usd
	slab	Increase Decrease In Other Current Liabilities And Income Taxes IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes	-13624000	usd
	slab	Increase Decrease In Other Current Liabilities And Income Taxes IncreaseDecreaseInOtherCurrentLiabilitiesAndIncomeTaxes	-26220000	usd
	slab	Increase Decrease In Deferred Revenue And Returns Liability IncreaseDecreaseInDeferredRevenueAndReturnsLiability	1206000	usd
	slab	Increase Decrease In Deferred Revenue And Returns Liability IncreaseDecreaseInDeferredRevenueAndReturnsLiability	4326000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-6703000	usd
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1975000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-55666000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15500000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	17700000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	81427000	usd
	slab	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	34538000	usd
	slab	Proceeds From Sale Of Marketable Securities ProceedsFromSaleOfMarketableSecurities	339555000	usd
	slab	Proceeds From Maturity Of Marketable Securities ProceedsFromMaturityOfMarketableSecurities	97458000	usd
	slab	Proceeds From Maturity Of Marketable Securities ProceedsFromMaturityOfMarketableSecurities	171691000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5577000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13462000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	12382000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	215000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	121101000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	416142000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	80000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	45000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	536124000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	201095000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15213000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	16310000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8108000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	7785000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-52105000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-665744000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	13330000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-265102000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	499915000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	240834000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	234813000	usd
	us-gaap	Fiscal Period FiscalPeriod	<div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company prepares financial statements on a 52- or 53-week fiscal year that ends on the Saturday closest to December 31. Fiscal 2024 will have 52 weeks and fiscal 2023 had 52 weeks. In a 52-week year, each fiscal quarter consists of 13 weeks.</span></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Among the significant estimates affecting the financial statements are those related to inventories, goodwill, acquired intangible assets, other long-lived assets, revenue recognition, stock-based compensation, and income taxes. Actual results could differ from those estimates, and such differences could be material to the financial statements. The Company periodically reviews the assumptions used in its financial statement estimates.</span></div>
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	10956000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-138683000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	24923000	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31614000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32018000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	31786000	shares
CY2023Q3	slab	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities	1312000	shares
	slab	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities	0	shares
	slab	Incremental Common Shares Attributable To Dilutive Effect Of Share Based Payment Arrangements And Conversion Of Debt Securities IncrementalCommonSharesAttributableToDilutiveEffectOfShareBasedPaymentArrangementsAndConversionOfDebtSecurities	1553000	shares
CY2023Q3	slab	Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations	32926000	shares
	slab	Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations	32018000	shares
	slab	Weighted Average Number Of Shares Outstanding Diluted Shares Used In Calculating Earnings Per Share Continuing Operations WeightedAverageNumberOfSharesOutstandingDilutedSharesUsedInCalculatingEarningsPerShareContinuingOperations	33339000	shares
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.75
CY2024Q2	slab	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod	300000	shares
CY2023Q3	slab	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod	900000	shares
	slab	Incremental Common Shares Attributable To Dilutive Effect Of Conversion Of Debt Securities Treasury Stock Method IncrementalCommonSharesAttributableToDilutiveEffectOfConversionOfDebtSecuritiesTreasuryStockMethod	1100000	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	147307000	usd
CY2024Q2	us-gaap	Short Term Investments ShortTermInvestments	98336000	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	245643000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	137195000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	211720000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	348915000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	245960000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	30000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	347000	usd
CY2024Q2	slab	Debt Securities Available For Sale And Cash Equivalents Fair Value DebtSecuritiesAvailableForSaleAndCashEquivalentsFairValue	245643000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	147307000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	98336000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	350144000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	206000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1435000	usd
CY2023Q4	slab	Debt Securities Available For Sale And Cash Equivalents Fair Value DebtSecuritiesAvailableForSaleAndCashEquivalentsFairValue	348915000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	137195000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	211720000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	71328000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	71133000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	27326000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	27203000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	98653000	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	98336000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	48489000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	114000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	29211000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	233000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	77700000	usd
CY2024Q2	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	347000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	40704000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	128000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	126882000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1307000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	167586000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1435000	usd
CY2024Q2	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	0.0	usd
	us-gaap	Contract With Customer Performance Obligation Satisfied In Previous Period ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod	2100000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	251742000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	491653000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	29455000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31377000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3802000	usd
	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	3941000	usd
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	25653000	usd
	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	27436000	usd
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	124400000	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y3M18D
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12300000	usd
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.530
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20100000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.446
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001628280-24-032746-index-headers.html	Edgar Link	pending
0001628280-24-032746-index.html	Edgar Link	pending
0001628280-24-032746.txt	Edgar Link	pending
0001628280-24-032746-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
slab-20240629.htm	Edgar Link	pending
slab-20240629.xsd	Edgar Link	pending
slab-20240629xexx311.htm	Edgar Link	pending
slab-20240629xexx312.htm	Edgar Link	pending
slab-20240629xexx321.htm	Edgar Link	pending
slab-20240629_def.xml	Edgar Link	unprocessable
slab-20240629_lab.xml	Edgar Link	unprocessable
slab-20240629_pre.xml	Edgar Link	unprocessable
slab-20240629_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
slab-20240629_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SLAB
Silicon Laboratories Inc Stock $slab

2024 Q3 Form 10-Q Financial Statement

#000162828024032746 Filed on July 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLAB Silicon Laboratories Inc Stock $slab

2024 Q3 Form 10-Q Financial Statement

#000162828024032746 Filed on July 24, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SLAB
Silicon Laboratories Inc Stock $slab